DR. MARK J JAGUST M.D. NPI 1467493494

NPI Details

DR. Mark J Jagust, M.D. is a family medicine in Lake Grove, NY with 39 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Mark J Jagust, M.D. NPI is 1467493494. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

2835 MIDDLE COUNTRY RD
LAKE GROVE, NY
ZIP 11755-105
Phone: (631) 467-3564
Fax: (631) 471-2236

The NPI 1467493494 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Hemoglobin a1c level (HCPCS:83036)
• Vitamin d-3 level (HCPCS:82306)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Thyroid hormone evaluation (HCPCS:84479)
• Magnesium level (HCPCS:83735)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Iron level (HCPCS:83540)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Folic acid level, serum (HCPCS:82746)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Face-to-face behavioral counseling for obesity, 15 minutes (HCPCS:G0447)
• Iron binding capacity (HCPCS:83550)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Uric acid level, blood (HCPCS:84550)
• Blood test, clotting time (HCPCS:85610)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Urinalysis, manual test (HCPCS:81002)
• Red blood count, manual test (HCPCS:85044)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Assessment of and care planning for impaired thought processing, typically 50 minutes (HCPCS:99483)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Assessment of emotional or behavioral problems (HCPCS:96127)
• Testosterone (hormone) level, total (HCPCS:84403)
• Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Phosphate level (HCPCS:84100)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Colonoscopy (HCPCS:NAN13)

The enumeration date for this NPI number is 6/9/2006 and was last updated on 8/10/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: